Form 4 for CPIX CUMBERLAND PHARMACEUTICALS INC

Accepted 2022-08-19 00:00:00 ET · period of report 2022-07-01 · accession 0001209191-22-046894 · SEC index · Original document

Summary rows

Aggregated the way they appear in lists: one row per insider, transaction code and security table.

X	Filed	Traded	Ticker	Insider	Title	Type	Price	Qty	Owned	ΔOwn	Value
M	2022-08-19	2022-07-01+	CPIX	Krogulski Kenneth	Dir	P - Purchase	$2.31	+3,566	192.7K	+2%	+$8,241

Purchase Sale Sale after option exercise All abbreviations

Every reported transaction

#	Table	Security	Date	Code	A/D	Shares	Price	Owned after	Own	Exercise / expiry	Underlying	Footnotes
1	Common	Common Stock	2022-08-04	P	A	124	$2.17	192,976	D	—	—	(F1) The purchases reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person during March 2022.
2	Common	Common Stock	2022-08-03	P	A	50	$2.45	192,852	D	—	—	(F1) The purchases reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person during March 2022.
3	Common	Common Stock	2022-08-08	P	A	138	$2.19	193,238	D	—	—	(F1) The purchases reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person during March 2022.
4	Common	Common Stock	2022-08-09	P	A	138	$2.19	193,376	D	—	—	(F1) The purchases reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person during March 2022.
5	Common	Common Stock	2022-08-10	P	A	138	$2.19	193,514	D	—	—	(F1) The purchases reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person during March 2022.
6	Common	Common Stock	2022-08-11	P	A	138	$2.46	193,652	D	—	—	(F1) The purchases reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person during March 2022.
7	Common	Common Stock	2022-08-12	P	A	138	$2.52	193,790	D	—	—	(F1) The purchases reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person during March 2022.
8	Common	Common Stock	2022-08-15	P	A	110	$2.45	193,900	D	—	—	(F1) The purchases reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person during March 2022.
9	Common	Common Stock	2022-08-05	P	A	124	$2.12	193,100	D	—	—	(F1) The purchases reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person during March 2022.
10	Common	Common Stock	2022-08-01	P	A	124	$2.34	192,802	D	—	—	(F1) The purchases reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person during March 2022.
11	Common	Common Stock	2022-07-01	P	A	130	$2.11	190,464	D	—	—	(F1) The purchases reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person during March 2022.
12	Common	Common Stock	2022-07-05	P	A	144	$2.18	190,608	D	—	—	(F1) The purchases reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person during March 2022.
13	Common	Common Stock	2022-07-06	P	A	144	$2.11	190,752	D	—	—	(F1) The purchases reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person during March 2022.
14	Common	Common Stock	2022-07-07	P	A	144	$2.18	190,896	D	—	—	(F1) The purchases reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person during March 2022.
15	Common	Common Stock	2022-07-08	P	A	144	$2.19	191,040	D	—	—	(F1) The purchases reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person during March 2022.
16	Common	Common Stock	2022-07-12	P	A	144	$2.25	191,184	D	—	—	(F1) The purchases reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person during March 2022.
17	Common	Common Stock	2022-07-14	P	A	144	$2.28	191,328	D	—	—	(F1) The purchases reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person during March 2022.
18	Common	Common Stock	2022-07-15	P	A	144	$2.23	191,472	D	—	—	(F1) The purchases reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person during March 2022.
19	Common	Common Stock	2022-07-18	P	A	124	$2.41	191,596	D	—	—	(F1) The purchases reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person during March 2022.
20	Common	Common Stock	2022-07-19	P	A	124	$2.47	191,720	D	—	—	(F1) The purchases reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person during March 2022.
21	Common	Common Stock	2022-07-20	P	A	124	$2.52	191,844	D	—	—	(F1) The purchases reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person during March 2022.
22	Common	Common Stock	2022-07-21	P	A	124	$2.54	191,968	D	—	—	(F1) The purchases reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person during March 2022.
23	Common	Common Stock	2022-07-22	P	A	124	$2.53	192,092	D	—	—	(F1) The purchases reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person during March 2022.
24	Common	Common Stock	2022-07-25	P	A	124	$2.48	192,216	D	—	—	(F1) The purchases reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person during March 2022.
25	Common	Common Stock	2022-07-26	P	A	124	$2.47	192,340	D	—	—	(F1) The purchases reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person during March 2022.
26	Common	Common Stock	2022-07-27	P	A	90	$2.36	192,430	D	—	—	(F1) The purchases reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person during March 2022.
27	Common	Common Stock	2022-07-28	P	A	124	$2.28	192,554	D	—	—	(F1) The purchases reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person during March 2022.
28	Common	Common Stock	2022-07-29	P	A	124	$2.28	192,678	D	—	—	(F1) The purchases reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person during March 2022.